aTyr Pharma Inc. (NASDAQ: LIFE) Attends 31st Annual ROTH Conference
aTyr Pharma (NASDAQ: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes. aTyr is focused on the therapeutic translation of the Resokine pathway, comprised of extracellular proteins derived from the histidyl tRNA synthetase gene family. For more information, visit the company's website at www.atyrpharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…







